Weijun Gu
Impact in
-
- Pituitary Gland Disorders and Treatments
- Growth Hormone and Insulin-like Growth Factors
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Thyroid Cancer Diagnosis and Treatment
- Diabetes Treatment and Management
- Adrenal Hormones and Disorders
- Nephrology top 10%
Papers in
-
- Pituitary Gland Disorders and Treatments 18
- Diabetes Management and Research 12
- Adrenal Hormones and Disorders 10
- Diabetes Treatment and Management 10
- Diabetes, Cardiovascular Risks, and Lipoproteins 8
- Journals
- Journal of Diabetes (6 papers)Frontiers in Endocrinology (6 papers)Medicine (5 papers)Diabetes Obesity and Metabolism (3 papers)Diabetes (2 papers)
- Partner nations
- ChinaPhilippinesUnited States
In The Last Decade
Weijun Gu
71 papers receiving 829 citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Endocrinology, Diabetes and Metabolism 402
- Nephrology 41
- Clinical Biochemistry 35
- Surgery 195
- Epidemiology 148
Countries citing papers authored by Weijun Gu
This map shows the geographic impact of Weijun Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijun Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijun Gu more than expected).
Fields of papers citing papers by Weijun Gu
This network shows the impact of papers produced by Weijun Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijun Gu. The network helps show where Weijun Gu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weijun Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 1 | |
| 10 | Prevalence of obesity and associated complications in China: A cross‐sectional, real‐world study in 15.8 million adults Hit paper breakdown → | 2023 | 175 |
| 11 | 2022 | 10 | |
| 12 | 2022 | 12 | |
| 13 | 2019 | 6 | |
| 14 | 2018 | 13 | |
| 15 | 2017 | 25 | |
| 16 | 2016 | 2 | |
| 17 | [A retrospective study of the impact of diabetes mellitus on survival in patients with lung cancer]. | 2015 | 0 |
| 18 | 2012 | 1 | |
| 19 | 2012 | 1 | |
| 20 | Diabetic ketoacidosis at diagnosis influences complete remission after treatment of hematopoietic stem cell transplantation in adolescents with type 1 diabetes | 2012 | 1 |
About Weijun Gu
Weijun Gu is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research, Nephrology, Surgery and Clinical Biochemistry, having authored 80 papers that have together received 838 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (18 papers), Diabetes Management and Research (12 papers), Adrenal and Paraganglionic Tumors (10 papers), Adrenal Hormones and Disorders (10 papers), Diabetes Treatment and Management (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Metabolism, Diabetes, and Cancer (7 papers) and Pancreatic function and diabetes (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (402 citations), Nephrology (41 citations), Clinical Biochemistry (35 citations), Surgery (195 citations) and Epidemiology (148 citations). Weijun Gu has collaborated with scholars based in China, Philippines and United States. Frequent co-authors include Yiming Mu, Jingtao Dou, Kang Chen, Zhaohui Lyu, Guoqing Yang, Yi Ning, Zewei Shen, Xuan Qi, Li Zang and Jianming Ba. Their work appears in journals such as Journal of Diabetes, Frontiers in Endocrinology, Medicine, Diabetes Obesity and Metabolism and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.